Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

Showing the 40 largest recruiting trials by target enrollment in Connecticut. Use the search field to focus on a condition or drug.

Recruiting 150,000 participants

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

Children's Hospital of Philadelphia

NCT02493478

Recruiting 120,000 participants

Computerized Registry of Patients With Venous Thromboembolism (RIETE)

Manuel Monreal

NCT02832245

Recruiting 100,000 participants

US National OCS Heart Perfusion (OHP) Registry

TransMedics

NCT05915299

Recruiting 80,000 participants

Generic Database of Very Low Birth Weight Infants

NICHD Neonatal Research Network

NCT00063063

Recruiting 75,000 participants

TrialNet Pathway to Prevention of T1D

University of South Florida

NCT00097292

Recruiting 68,000 participants

Follow-up Visit of High Risk Infants

NICHD Neonatal Research Network

NCT00009633

Recruiting NA 61,770 participants

TRUsted rEsidents and Housing Assistance to Decrease Violence Exposure in New Haven

Yale University

NCT05723614

Recruiting 50,000 participants

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio

NCT03452774

Recruiting 40,000 participants

Stroke Thrombectomy and Aneurysm Registry

Medical University of South Carolina

NCT04994756

Recruiting 40,000 participants

Real-Time Monitoring of Heart Failure Across the Yale New Haven Health System

Yale University

NCT04237701

Recruiting 35,000 participants

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

CHDI Foundation

NCT01574053

Recruiting 30,000 participants

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Agendia

NCT03053193

Recruiting 25,000 participants

Parkinson's Foundation PD GENEration Genetic Registry

Parkinson's Foundation

NCT04994015

Recruiting Phase 4 20,000 participants

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Duke University

NCT04262206

Recruiting 20,000 participants

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Duke University

NCT02418442

Recruiting 20,000 participants

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Freenome Holdings

NCT06122077

Recruiting 20,000 participants

Pancreatic Cancer Early Detection Consortium

Arbor Research Collaborative for Health

NCT04970056

Recruiting 15,000 participants

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Target PharmaSolutions

NCT02815891

Recruiting 15,000 participants

Patient Retrospective Outcomes (PRO)

Boston Scientific Corporation

NCT01550575

Recruiting NA 13,000 participants

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Washington University School of Medicine

NCT05991453

Recruiting Phase 3 13,000 participants

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Hoffmann-La Roche

NCT07177352

Recruiting 12,000 participants

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

Genzyme, a Sanofi Company

NCT00358943

Recruiting Phase 3 10,450 participants

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

Eli Lilly and Company

NCT07157774

Recruiting 10,000 participants

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Cure HHT

NCT06259292

Recruiting Phase 2 10,000 participants

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

Eli Lilly and Company

NCT05986292

Recruiting 10,000 participants

An Evaluation of Hip Preservation Outcomes

Yale University

NCT05746533

Recruiting Phase 3 9,000 participants

The Cancer of the Pancreas Screening-5 CAPS5)Study

Johns Hopkins University

NCT02000089

Recruiting 9,000 participants

Fabry Disease Registry & Pregnancy Sub-registry

Genzyme, a Sanofi Company

NCT00196742

Recruiting Phase 4 7,410 participants

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

VA Office of Research and Development

NCT02915198

Recruiting 7,000 participants

Genetic Analysis of Keloids

UConn Health

NCT01619553

Recruiting Phase 3 6,150 participants

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

Population Health Research Institute

NCT04774159

Recruiting NA 6,080 participants

Annual Wellness Visits vs GRACE-augmented Annual Wellness Visits For Older Adults With High Needs - Phase 2

Massachusetts General Hospital

NCT07166861

Recruiting NA 6,030 participants

Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension

Yale University

NCT05884190

Recruiting Phase 3 6,000 participants

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Boehringer Ingelheim

NCT06424288

Recruiting Phase 4 6,000 participants

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Duke University

NCT06909565

Recruiting Phase 3 5,500 participants

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)

AstraZeneca

NCT05952557

Recruiting NA 5,200 participants

MyChart Proxy Outreach to Parents (MyPOP)

Yale University

NCT05989308

Recruiting 5,000 participants

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

National Cancer Institute LAO

NCT02474160

Recruiting Phase 2 5,000 participants

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

QuantumLeap Healthcare Collaborative

NCT01042379

Recruiting 5,000 participants

Rheumatology Patient Registry and Biorepository

Yale University

NCT04402086

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →